Haley P E, Doyle M F, Mann K G
Department of Biochemistry, University of Vermont College of Medicine, 05405-0068.
J Biol Chem. 1989 Sep 25;264(27):16303-10.
A complex composed of factor Xa and phospholipid vesicles assembled in the presence of calcium ions catalyzes a discrete cleavage of the heavy chain of bovine protein C that is indistinguishable from that produced by thrombin as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. This cleavage generates an active site capable of hydrolyzing small substrates and inactivating factor Va function in the prothrombinase complex. Activation of protein C by factor Xa requires both calcium ions and phospholipid vesicles and proceeds at a rate an order of magnitude greater than that observed for alpha-thrombin in solution. gamma-Carboxyglutamic acid-domainless protein C is not activated by factor Xa, consistent with the requirement for phospholipid and distinguishing this reaction from protein C activation by thrombin. Thrombomodulin serves as a cofactor for the factor Xa-catalyzed reaction, forming a 1:1 complex with factor Xa (apparent Kd = 5.7 X 10(-10) M) and stimulating the saturated rate of protein C activation by factor Xa (kcat = 149 min-1) to levels comparable with the thrombin-thrombomodulin complex. Protein C activation by factor Xa is not inhibited by the specific thrombin inhibitor dansyl-N-(3-ethyl-1,5-pentanediyl)amide but is inhibited by antithrombin III, tripeptide-chloromethyl ketones, and the monoclonal antibody alpha-BFX-2b that is highly specific for factor Xa. These data indicate that thrombomodulin is promiscuous in its role as a cofactor and suggest the existence of an alternative pathway for protein C activation in vivo.
由因子Xa和在钙离子存在下组装的磷脂囊泡组成的复合物催化牛蛋白C重链的离散切割,通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳判断,这种切割与凝血酶产生的切割无法区分。这种切割产生一个能够水解小底物并使凝血酶原酶复合物中因子Va功能失活的活性位点。因子Xa对蛋白C的激活需要钙离子和磷脂囊泡,其反应速率比溶液中α-凝血酶观察到的速率高一个数量级。无γ-羧基谷氨酸结构域的蛋白C不能被因子Xa激活,这与对磷脂的需求一致,并将此反应与凝血酶对蛋白C的激活区分开来。血栓调节蛋白作为因子Xa催化反应的辅因子,与因子Xa形成1:1复合物(表观Kd = 5.7×10^(-10) M),并将因子Xa激活蛋白C的饱和速率(kcat = 149 min^(-1))提高到与凝血酶 - 血栓调节蛋白复合物相当的水平。因子Xa对蛋白C的激活不受特异性凝血酶抑制剂丹磺酰 - N - (3 - 乙基 - 1,5 - 戊二酰基)酰胺的抑制,但受抗凝血酶III、三肽 - 氯甲基酮和对因子Xa高度特异性的单克隆抗体α - BFX - 2b的抑制。这些数据表明血栓调节蛋白作为辅因子的作用具有混杂性,并提示体内存在蛋白C激活的替代途径。